ORLANDO, Fla., July 7 /PRNewswire-FirstCall/ -- Bio-One Corporation
(OTC Bulletin Board: BICO) announced today that its revenue for the second
fiscal quarter ended June 30, 2004 will exceed $13 million. The company said
it expects operating profits to be approximately $2 million. The company
reported no revenues a year ago.
Bio-One President and CEO Armand Dauplaise said, "The final numbers for
the quarter are not yet in, but at this point it looks as if we are close to
our internal projections for the quarter, which means we should report
revenues in excess of $13 million. These results reflect the impact of our
continuing acquisitions and vertical integration program."
Since September 2003, Bio-One has acquired five companies, which
collectively reported 2003 audited revenues of $38 million and operating
profits (EBITDA) of $5.8 million. They are: PNLabs: Acquired September 2003. $1 million nutritional supplements
marketer.
American Nutritional Exchange: Acquired 80% interest February 2004.
$7.1 million supplements distributor.
Interactive Nutrition International: Acquired March 2004. $12 million
manufacturer and distributor of branded supplements.
WeiFang Shengtai Pharmaceuticals: Acquired 51% April 2004. $16.3 million
Chinese glucose manufacturer.
Florida Sport Nutrition Distributors: Acquired June 2004. $2 million
supplements distributor.
About Bio-One
Bio-One Corporation is a nutritional supplements company serving the
preventive and alternative healthcare segments. The company intends to acquire
additional businesses in order to provide quality nutraceuticals to consumers
through vertical integration of manufacturing, distribution and marketing.
Current Bio-One subsidiaries include PNLabs, American Nutritional Exchange,
Interactive Nutrition International, Nutrition Sciences Corporation, WeiFang
Shengtai Pharmaceuticals Co. Ltd. and ANI Distribution.
Bio-One Corporation is committed to its mission of the continuing pursuit
of excellence in serving its customers, suppliers, team members and
shareholders. Bio-One is confident that it will accomplish its mission and
goals through the application of its management philosophy, which is to treat
others the way they would want to be treated themselves.
An investment profile on Bio-One Corporation may be found at http://www.hawkassociates.com/bioone/profile.htm.
For investor relations information, contact Frank Hawkins or Julie
Marshall, Hawk Associates at (305) 852-2383, email: info@hawkassociates.com.
For Bio-One information contact Bob Gartzman at 888-327-4703. Detailed
information about Bio-One may be found on the website http://www.bioonecorp.com. Copies of Bio-One press releases, current Level II
price quotes, interactive and Java stock charts and other valuable information
for investors may be found on the websites http://www.hawkassociates.com and http://www.hawkmicrocaps.com
Certain statements released by Bio-One Corporation that are forward-
looking statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Editors and investors are
cautioned that forward-looking statements involve risk and uncertainties that
may affect the company's business prospects and performance. These include,
but are not limited to, economic, competitive, governmental, technological and
other risks detailed in the company's registration statements and periodic
reports filed with the Securities and Exchange Commission. By making these
forward-looking statements, the company undertakes no obligation to update
these statements for revisions or changes after the date of this release.
SOURCE Bio-One Corporation
-0- 07/07/2004
/CONTACT: Bob Gartzman, Bio-One Corporation, +1-888-327-4703; or Frank
Hawkins or Julie Marshall, Hawk Associates, +1-305-852-2383, or
info@hawkassociates.com, for Bio-One Corporation/
/Web site: http://www.bioonecorp.com /
(BICO)
CO: Bio-One Corporation
ST: Florida, China
IN: BIO OTC MTC HEA
SU: ERP
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
